Probing intratumoral metabolic compartmentalisation in fumarate hydratase-deficient renal cancer using clinical hyperpolarised 13C-MRI and mass spectrometry imaging
Horvat-Menih, I.; Casey, R.; Denholm, J.; Hamm, G.; Hulme, H.; Gallon, J.; Khan, A. S.; Kaggie, J.; Gill, A. B.; Priest, A. N.; Duarte, J. A. G.; Yong, C.; Brodie, C.; Whitworth, J.; Barry, S. T.; Goodwin, R. J. A.; Anand, S.; Dodd, M.; Honan, K.; Welsh, S. J.; Warren, A. Y.; Aho, T.; Stewart, G. D.; Mitchell, T. J.; McLean, M. A.; Gallagher, F. A.
Show abstract
BackgroundFumarate hydratase-deficient renal cell carcinoma (FHd-RCC) is a rare and aggressive renal cancer subtype characterised by increased fumarate accumulation and upregulated lactate production. Renal tumours demonstrate significant intratumoral metabolic heterogeneity, which may contribute to treatment failure. Emerging non-invasive metabolic imaging techniques have clinical potential to more accurately phenotype tumour metabolism and its heterogeneity. MethodsHere we have used hyperpolarised 13C-pyruvate MRI (HP 13C-MRI) to assess 13C-lactate generation in a patient with an organ-confined FHd-RCC. Post-operative tissue samples were co-registered with imaging and underwent sequencing, IHC staining, and mass spectrometry imaging (MSI). ResultsHP 13C-MRI revealed two metabolically distinct tumour regions. The 13C-lactate-rich region showed a high lactate/pyruvate ratio and slightly lower fumarate on MSI compared to the other tumour region, as well as increased CD8+ T cell infiltration, and genetic dedifferentiation. Compared to the normal kidney, vascularity in tumour was decreased, while immune cell fraction was markedly higher. ConclusionsThis study shows the potential of metabolic HP 13C-MRI to characterise FHd-RCC and how targeting of biopsies to regions of metabolic dysregulation could be used to obtain the tumour samples of greatest clinical significance, which in turn can inform on early and successful response to treatment.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies. 92%
- Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer 92%
- Extensive patient-to-patient single nuclei transcriptome heterogeneity in pheochromocytomas and paragangliomas 91%
Similar papers in this journal
- Post-ischemic inactivation of HIF prolyl hydroxylases in endothelium promotes maladaptive kidney repair by inducing glycolysis 93%
- Intraoperative arteriovenous patient sampling to assess in situ non-small cell lung cancer metabolism 92%
- Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis 92%
Similar papers in this journal
- Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy 92%
- Diffusion Histology Imaging Combining Diffusion Basis Spectrum Imaging (DBSI) and Machine Learning Improves Detection and Classification of Glioblastoma Pathology 90%
- Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome 90%
Similar papers in this journal
- Transcriptome and fatty-acid signatures of adipocyte hypertrophy and its non-invasive MR-based characterization in human adipose tissue 90%
- Transfer of hepatocellular microRNA regulates cytochrome P450 2E1 in renal tubular cells 89%
- Precision Diagnostic Approach to Predict 5-year Risk for Microvascular Complications in Type 1 Diabetes 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.